Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Alnylam Pharmaceuticals, Inc. (ALNY)

« Back to company index

ALNY Chatter Timeline

Stock Ticker for ALNY

Most Active Tweeters for ALNY

UserTweets
@TranscriptDaily 6
@Steve_382 6
@stocknewstimes 6
@otcdynamics 4
@TheMarketsDaily 4

Recent Tweets for ALNY

BACScoreChanges @BACScoreChanges
#AlnylamPharmaceuticals $ALNY BidaskScore is Lowered to Sold https://t.co/1HUrqsgwbY
October 22nd 2020, 8:10pm
otcdynamics @otcdynamics
$ALNY Alnylam to Webcast Conference Call Discussing Third Quarter 2020 Financial Results https://t.co/Lexf53gg0h
October 22nd 2020, 4:10pm
FlashAlert_me @FlashAlert_me
$ALNY [15s. delayed]: Issued Press Release on October 22, 16:00:00: Alnylam to Webcast Conference Call Discussing T… https://t.co/lGFhiFNtGA
October 22nd 2020, 4:10pm
stock_titan @stock_titan
$ALNY Alnylam to Webcast Conference Call Discussing Third Quarter 2020 Financial Results https://t.co/Kx17rGA5FH
October 22nd 2020, 4:10pm
Briefingcom @Briefingcom
$ALNY: Alnylam Pharma announced results from the 6-month primary analysis of the ILLUMINATE-B Phase 3 pediatric... https://t.co/NBRitfS0l4
October 22nd 2020, 12:10pm
newsfilterio @newsfilterio
Alnylam's lumasiran shows treatment benefit in rare kidney disorder $ALNY https://t.co/x1A7jKnG9C
October 22nd 2020, 10:10am
HealthcareBeat @HealthcareBeat
Alnylam's lumasiran shows treatment benefit in rare kidney disorder $ALNY https://t.co/Eardo6HRDH
October 22nd 2020, 10:10am
MarketCurrents @MarketCurrents
$ALNY - Alnylam's lumasiran shows treatment benefit in rare kidney disorder https://t.co/86c3klujaD
October 22nd 2020, 10:10am
sbwcws @sbwcws
Alnylam: Lumasiran showed 72% reduction in urinary oxalate in Phase 3 study $ALNY
October 22nd 2020, 10:10am
otcdynamics @otcdynamics
$ALNY Alnylam Presents Positive Results from ILLUMINATE-B Phase 3 Study in Pediatric Patients with Primary Hyperoxa… https://t.co/Am68OFikUv
October 22nd 2020, 10:10am
FlashAlert_me @FlashAlert_me
$ALNY [15s. delayed]: Issued Press Release on October 22, 10:00:00: Alnylam Presents Positive Results from ILLUMINA… https://t.co/vrXTrD2XZj
October 22nd 2020, 10:10am
stock_titan @stock_titan
$ALNY Alnylam Presents Positive Results from ILLUMINATE-B Phase 3 Study in Pediatric Patients with Primary Hyperoxa… https://t.co/eObPauD2cZ
October 22nd 2020, 10:10am
WatchlistN @WatchlistN
Analysts Expect Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Quarterly Sales of $117.53 Million https://t.co/pcQiu9dxTM
October 22nd 2020, 1:10am
KillerStockCall @KillerStockCall
Potential Near Future Catalysts $ALNY Drug: ALN-GO1 Date: 22 Oct 2020 Full Results Phase 3 $OMER Drug: OMS721 Da… https://t.co/BWok44mHrT
October 21st 2020, 9:10pm
Steve_382 @Steve_382
$ALNY Topline results from the ILLUMINATE-B pediatric study were reported in September; results from the primary a… https://t.co/KxuxbLeL11
October 21st 2020, 12:10pm
stocknewstimes @stocknewstimes
FY2020 Earnings Estimate for Alnylam Pharmaceuticals, Inc. Issued By Jefferies Financial Group $ALNY https://t.co/kkddAgYSIG
October 21st 2020, 11:10am
TranscriptDaily @TranscriptDaily
FY2020 Earnings Estimate for Alnylam Pharmaceuticals, Inc. Issued By Jefferies Financial Group $ALNY https://t.co/YzM3G4ojj2
October 21st 2020, 11:10am
TheMarketsDaily @TheMarketsDaily
FY2020 EPS Estimates for Alnylam Pharmaceuticals, Inc. Cut by Analyst $ALNY https://t.co/1PnW620alF
October 21st 2020, 11:10am
TranscriptDaily @TranscriptDaily
FY2020 Earnings Forecast for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/RcH6B7e8y3
October 21st 2020, 11:10am
EnterpriseLeade @EnterpriseLeade
FY2020 Earnings Forecast for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/YGlOSikB5Q
October 21st 2020, 11:10am
TheMarketsDaily @TheMarketsDaily
FY2020 Earnings Estimate for Alnylam Pharmaceuticals, Inc. Issued By Jefferies Financial Group $ALNY https://t.co/erpy4P4AAx
October 21st 2020, 11:10am
TranscriptDaily @TranscriptDaily
FY2020 Earnings Estimate for Alnylam Pharmaceuticals, Inc. Issued By Jefferies Financial Group $ALNY https://t.co/Zs9CddBdao
October 21st 2020, 11:10am
stocknewstimes @stocknewstimes
FY2020 Earnings Forecast for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/16T3Pezoi9
October 21st 2020, 11:10am
WatchlistN @WatchlistN
Jefferies Financial Group Research Analysts Reduce Earnings Estimates for Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/kWxinnDYMt
October 21st 2020, 3:10am
AmericanBanking @AmericanBanking
Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY to Post -$1.75 Earnings Per Share https://t.co/YpxvfuhRhU #stocks
October 20th 2020, 9:10pm
BlueBioNow @BlueBioNow
$ALNY I'd like to make an exit, just not now -3.27 % change recently https://t.co/aSQcF6S6Ua
October 20th 2020, 9:10pm
Steve_382 @Steve_382
@DewDiligence That $ALNY $VIR chat was very interesting. Over my head scientifically, but the cooperation seems very sincere.
October 20th 2020, 1:10pm
dispatchtribune @dispatchtribune
FY2024 Earnings Estimate for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/wv135MSAFh
October 20th 2020, 6:10am
AmericanBanking @AmericanBanking
FY2024 Earnings Estimate for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/uV2N0GxiHA #stocks
October 20th 2020, 6:10am
ZolmaxNews @ZolmaxNews
FY2024 Earnings Estimate for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/RXLFoeodML
October 20th 2020, 6:10am
BlueBioNow @BlueBioNow
$ALNY Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. -3.56 % change recently https://t.co/aSQcF6S6Ua
October 20th 2020, 6:10am
thegreenisback @thegreenisback
Is Ionis Pharmaceuticals a Buy? @themotleyfool #stocks $IONS $ALNY https://t.co/06SwKFYnfI
October 19th 2020, 2:10pm
Steve_382 @Steve_382
$ALNY $VIR I don't expect much from this, but tomorrow at 12:30 ET. Both stocks hammered today in advance. Vir and… https://t.co/dahw23xPXt
October 19th 2020, 2:10pm
AlertTrade @AlertTrade
RT @AlertTrade: REVERSALtoDOWN: $ALNY Alnylam Pharmaceuticals, Inc https://t.co/wedZS50nBI ? ? TradeIdeas via ? https://t.co/ZgCyz4rX3x
October 19th 2020, 1:10pm
AlertTrade @AlertTrade
REVERSALtoDOWN: $ALNY Alnylam Pharmaceuticals, Inc https://t.co/wedZS50nBI ? ? TradeIdeas via ? https://t.co/ZgCyz4rX3x
October 19th 2020, 12:10pm
OTSociety @OTSociety
RT @RNAiAnalyst: $ALNY not only 1, but 2 European CHMP positive opinions on 1 day. In addition to $NVS-partnered LDLc-lowering PCSK9 RNAi,…
October 19th 2020, 7:10am
TranscriptDaily @TranscriptDaily
Bank of America Cuts Alnylam Pharmaceuticals $ALNY Price Target to $157.00 https://t.co/0kc8u6uDQO
October 19th 2020, 3:10am
TheMarketsDaily @TheMarketsDaily
Alnylam Pharmaceuticals $ALNY PT Lowered to $157.00 at Bank of America https://t.co/HoT1JD7sOO
October 19th 2020, 3:10am
wh3atth1nz @wh3atth1nz
$ALNY reclaimed the 50 day SMA and forming a low handle type consolidation. https://t.co/xvRDB3MmCP
October 18th 2020, 5:10pm
thegreenisback @thegreenisback
The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer Conference $ABT $ALNY… https://t.co/v4sHExaCUj
October 18th 2020, 1:10pm
RipShowStocks @RipShowStocks
$ALNY Consolidating before its next move higher. Levels, resistance/support to trade: https://t.co/2lPePBh04u
October 18th 2020, 1:10pm
Gambiste1 @Gambiste1
RT @WhyteStocks: Just In: $ALNY Can Either of These Little-Known Biotechs Find New Life Fighting Coronavirus? In 1962, the Nob $ALNY http…
October 18th 2020, 9:10am
WhyteStocks @WhyteStocks
Just In: $ALNY Can Either of These Little-Known Biotechs Find New Life Fighting Coronavirus? In 1962, the Nob… https://t.co/MQKfQ2Qxwo
October 18th 2020, 7:10am
dispatchtribune @dispatchtribune
Bank of America Trims Alnylam Pharmaceuticals $ALNY Target Price to $157.00 https://t.co/M7eHjyerDC
October 18th 2020, 4:10am
ZolmaxNews @ZolmaxNews
Bank of America Trims Alnylam Pharmaceuticals $ALNY Target Price to $157.00 https://t.co/rmsb88vyYv
October 18th 2020, 4:10am
Amarshall7M @Amarshall7M
@RNAiAnalyst I was a bit surprised this news was as priced in as it appears to be. O patrol is clearly a show me story. $ALNY
October 17th 2020, 10:10am
HealthcareBeat @HealthcareBeat
European advisory group backs Alnylam's lumasiran in rare inherited liver disorder $ALNY https://t.co/8AYVF9Wpze
October 17th 2020, 6:10am
RNAiAnalyst @RNAiAnalyst
$ALNY not only 1, but 2 European CHMP positive opinions on 1 day. In addition to $NVS-partnered LDLc-lowering PCSK9… https://t.co/vqu3GZl3Qz
October 17th 2020, 4:10am
equity_newswire @equity_newswire
$ALNY Alnylam Receives Positive CHMP Opinion for OXLUMO™ (lumasiran) for the Treatment of Primary Hyperoxaluria Typ… https://t.co/lzKAwKMBZR
October 16th 2020, 6:10pm
MaisaCorp @MaisaCorp
$ALNY said Friday the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended th… https://t.co/HmbhFeBEyy
October 16th 2020, 3:10pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.